239th ENMC International Workshop: Classification of dermatomyositis, Amsterdam, the Netherlands, 14-16 December 2018

Neuromuscul Disord. 2020 Jan;30(1):70-92. doi: 10.1016/j.nmd.2019.10.005. Epub 2019 Oct 25.

Authors

Andrew L Mammen¹, Yves Allenbach², Werner Stenzel³, Olivier Benveniste²; ENMC 239th Workshop Study Group

Collaborators

ENMC 239th Workshop Study Group:
Yves Allenbach⁴, Olivier Benveniste⁴, Jan De Bleecker⁴, Olivier Boyer⁴, Livia Casciola-Rosen⁴, Lisa Christopher-Stine⁴, Jan Damoiseaux⁴, Cyril Gitiaux⁴, Manabu Fujimoto⁴, Janine Lamb⁴, Océane Landon-Cardinal⁴, Ingrid E Lundberg⁴, Andrew Mammen⁴, Ichizo Nishino⁴, Josefine Radke⁴, Albert Selva-O'Callaghan⁴, Werner Stenzel⁴, Jiri Vencovsky⁴, Marianne de Visser⁴, Guochun Wang⁴, Lucy Wedderburn⁴, Victoria Werth⁴

Affiliations

¹ Muscle Disease Unit, Laboratory of Muscle Stem Cells and Gene Regulation, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, 50 South Drive, Building 50, Room 1146, MD 20892, United States. Electronic address: andrew.mammen@nih.gov.
² Department of Internal Medicine and Clinical Immunology, Pitié Salpetrière Hospital, AP-HP Sorbonne University, Paris, France.
³ Department of Neuropathology, Charité-Universitatsmedizin, Berlin, Germany.
⁴ (France).

PMID: 31791867
DOI: 10.1016/j.nmd.2019.10.005

No abstract available

Keywords: Antisynthetase syndrome; Autoantibodies; Classification; Dermatomyositis; Myositis.

Publication types

Clinical Conference
Research Support, Non-U.S. Gov't

MeSH terms

Autoantibodies*
Biomarkers
Congresses as Topic*
Dermatomyositis / classification*
Dermatomyositis / diagnosis
Dermatomyositis / immunology
Humans
Myositis / classification
Myositis / diagnosis
Myositis / immunology
Netherlands

Substances

Autoantibodies
Biomarkers

Supplementary concepts

Antisynthetase syndrome

Grants and funding